FDA approves Epoetin Alfa use for AZT patients.
D000740:Anemia / Q000139:chemically induced / Q000628:therapy*; D004921:Erythropoietin / Q000627:therapeutic use*; D015658:HIV Infections / Q000188:drug therapy*; D015497:HIV-1; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration; D015215:Zidovudine / Q000009:adverse effects*
D004921:Erythropoietin; D015215:Zidovudine